Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

NCT06357676 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
PROCEDURE: FDG-Positron Emission Tomography
BIOLOGICAL: Glofitamab
DRUG: Ibrutinib
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Obinutuzumab

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]